Global Infectious Disease Market 2025-2029

Infectious Disease Market 2025-2029

The infectious disease market is forecasted to grow by USD 160.8 billion during 2024-2029, accelerating at a CAGR of 14.7% during the forecast period. The report on the infectious disease market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by increasing prevalence of infectious diseases, growing awareness of infectious diseases, and strong drug pipeline.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market size data, segment with regional analysis and vendor landscape in addition to an analysis of the key companies. Reports have historic and forecast data.

Technavio's infectious disease market is segmented as below:

By Product

• Drugs
• Vaccines

By End-user

• Hospital
• Multispecialty clinic
• Others

By Type

• Bacterial infections
• Viral infections
• Fungal infections
• Parasitic infections

By Geographical Landscape

• North America
• Europe
• Asia
• Rest of World (ROW)

This study identifies the development of novel drugs as one of the prime reasons driving the infectious disease market growth during the next few years. Also, increasing mergers and acquisitions and emergence of new patterns of infectious diseases will lead to sizable demand in the market.

The report on the infectious disease market covers the following areas:

• Infectious Disease Market sizing
• Infectious Disease Market forecast
• Infectious Disease Market industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading infectious disease market vendors that include Abbott Laboratories, Becton Dickinson and Co., Bio RAD Laboratories Inc., BioMerieux SA, Danaher Corp., DiaSorin SpA, F. Hoffmann La Roche Ltd., Genetic Signatures Ltd., Grifols SA, Hologic Inc., Meridian Bioscience Inc., Meril Life Sciences Pvt. Ltd., OraSure Technologies Inc., Perkin Elmer Inc., QIAGEN N.V., QuidelOrtho Corp., Siemens Healthineers AG, Sysmex Corp., Thermo Fisher Scientific Inc., and Trinity Biotech PLC. Also, the infectious disease market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth. Show more